SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-138263
Filing Date
2024-05-14
Accepted
2024-05-14 16:20:59
Documents
16
Period of Report
2024-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d693344d8k.htm   iXBRL 8-K 28062
2 EX-99.1 d693344dex991.htm EX-99.1 62848
7 GRAPHIC g693344g0513233738685.jpg GRAPHIC 4016
  Complete submission text file 0001193125-24-138263.txt   263549

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20240514.xsd EX-101.SCH 3878
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20240514_def.xml EX-101.DEF 13653
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20240514_lab.xml EX-101.LAB 22565
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20240514_pre.xml EX-101.PRE 14621
19 EXTRACTED XBRL INSTANCE DOCUMENT d693344d8k_htm.xml XML 5700
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 24944692
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)